CN106667440A - Chargeable system for detecting pathological change of tissue - Google Patents
Chargeable system for detecting pathological change of tissue Download PDFInfo
- Publication number
- CN106667440A CN106667440A CN201611268447.2A CN201611268447A CN106667440A CN 106667440 A CN106667440 A CN 106667440A CN 201611268447 A CN201611268447 A CN 201611268447A CN 106667440 A CN106667440 A CN 106667440A
- Authority
- CN
- China
- Prior art keywords
- module
- communication module
- lesion
- implantable medical
- communication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1072—Measuring physical dimensions, e.g. size of the entire body or parts thereof measuring distances on the body, e.g. measuring length, height or thickness
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0858—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving measuring tissue layers, e.g. skin, interfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
Abstract
The invention discloses a chargeable system for detecting the pathological change of tissue. The chargeable system comprises an implantable medical device and an in-vitro detector. The implantable medical device is implanted in a patient body and comprises a sensor module, a first processor module, a charging coil, at least one main battery, at least one standby battery, an awakening module and a first communication module. The in-vitro detector is arranged in an in-vitro mode and comprises an ultrasonic wave generating module, an ultrasonic wave receiving module, a second processor module, an early warning module and a second communication module for wireless communication. The first processor module controls the charging coil and the standby battery to charge the main battery. Electric energy of the chargeable system for detecting the pathological change of the tissue is rapidly supplemented through the charging system.
Description
Technical field
The present invention relates to a kind of medical implant system, in particular to a kind of lesion tissue detecting system of charging.
Background technology
Various implantable medical devices（IMDS）It is including the pacemaker for clinical implanted device, defibrillator, its
His electrical stimulation device includes spinal cord, brain deep, nerve, muscular irritation, drug delivery system, heart and other physiological monitors,
Artificial cochlea etc..Although the surgery of implanted device is the material compatible with tissue, such as titanium, but is gone back after human body is implanted into
It is to have due to friction or the risk for causing surrounding tissue ulceration, infecting that rejects.Implantable medical device implantation human body after by
Cause surrounding tissue inflammation, ulceration in factors such as friction, rejection, infection；Typically now use B ultrasonic or ultrasonic development technology
Lesion is analyzed, the method needs patient to be checked to hospital.But, regarded the trouble of implantable medical device operation
Person has found that wound is abnormal and when arriving examination in hospital, has had already passed by best occasion for the treatment.
Chinese patent CN104958075A discloses a kind of using Raman spectrum non-invasive measurement skin thickness and blood sugar
Concentration and its calibration method, wherein measuring the noninvasive method of person under inspection's skin thickness and blood sugar concentration by Raman system.
Advantage is, it uses single Raman spectrum to measure skin thickness and blood sugar concentration, and the skin as obtained by same Raman spectrum
Skin thickness data and raman scattering intensity data are combined to obtain more accurate blood sugar concentration.
It can be seen that, implantable medical device surrounding skin thickness is detected at any time after implantable medical device implantation human body, and
Ulceration situation to tissue around carries out early warning；In addition, carrying out timely quick charge to the implantable medical device.
The content of the invention
It is an object of the invention in overcoming the shortcomings of above-mentioned technology, there is provided a kind of lesion tissue detecting system of charging,
Including, implantable medical device and vitro detection device；Implantable medical device implantation within a patient, including sensor, at first
Reason device module, at least charge coil, at least a main battery, a reserve battery, wake module and first communication module；First treatment
Device module control charge coil charges to an at least main battery and an at least reserve battery；First processor module control at least one
Reserve battery charges to an at least main battery.
Vitro detection device, is set in vitro, including ultrasonic wave occurs module, ultrasonic wave receiver module, second processing device mould
Block, second communication module, warning module, implantable medical device can be with the of skin detectors by its first communication module
Two communication modules carry out radio communication；Sensor may include that body temperature trans, germ sensor, starch enzyme sensor, antibody are passed
Sensor；The second processing device module of vitro detection device periodically controls ultrasonic wave transmitter module and ultrasonic wave receiver module detection wound
Neighbouring skin thickness, when skin thickness intensity of variation is more than the first lesion threshold value, then may group around implantable medical device
The sick change of hair-weaving, is communicated by second communication module with the first communication module of implantable medical device, and sending may lesion letter
Breath；Postprocessor module control wake module wake up sensor further detect, carry out body temperature, germ, amylase or antibody
Detection, body temperature trans can be located at patient oxter, and germ sensor can be located at the border circular areas that wound radius is 3-5cm
It is interior, if testing result reaches the second lesion threshold value, it is determined that implanted device tissue around lesion, by first communication module with
Pathological Information is sent to vitro detection device by second communication module, and second processing device module control warning module carries out early warning.
Further, the system may also include remote server and doctor's main frame, and vitro detection device may also include threeway
Letter module, the third communication module of vitro detection device can be by being wirelessly or non-wirelessly connected to remote server, and warning module is pre-
Pathological Information is also sent to by remote server by third communication module after police, is available for doctor to be accessed in doctor's main frame.
Further, the sensor of implantable medical device can periodically be waken up detection implantable medical device tissue around
Physiological parameter and vitro detection device is sent to by first communication module and second communication module, and by third communication module
Remote server is uploaded to, doctor can check patient data by doctor's main frame.
Further, main battery and reserve battery are Li-Ion rechargeable battery or other rechargeable batteries, or are filled soon
Battery.
Brief description of the drawings
Fig. 1 is the lesion tissue detecting system figure of charging of the invention.
The doctor's main frame of 101. implantable medical device, 102. monitored in vitro device, 103. remote server 104..
The first communication module of 201. sensor, 202. first processor module, 203. wake module 204..
301. ultrasonic vocalization module, 302. ultrasonic wave receiver module, 303. second processing device module 304. second communicates
The third communication module of 305. warning module of module 306..
Specific embodiment
The present invention is further described with reference to the accompanying drawings and examples.
Accompanying drawing 1 shows the lesion tissue detecting system schematic diagram of the charging that treatment is provided to patient.The system includes planting
Enter medical treatment device 101 and monitored in vitro device 102, implantable medical device can be that any suitable offer to patient is treated
Implanted device, it generates and delivers electro photoluminescence to body nerve and organize the treatment for various biological disorders, e.g.
The device of heart rate management treatment is provided to heart, it is possible to including for example implantable pacemaker, heart multiple rate device and/or defibrillation
Device, these devices can provide treatment via lead etc. to patient's heart；Cochlear stimulation device, the treatment blindness of deafness are for example treated again
Retina stimulator, the ailing spinal stimulator of the limb motion muscle stimulator that produces collaboration, treatment etc..Implantable medical
Device can also be the electrocardiosignal and/or other physiological parameters for sensing patient's heart（For example, blood oxygen saturation, blood pressure,
Heart rate, body temperature, respiratory rate etc.）, and above-mentioned signal and/or physiological parameter are stored to be recorded, analyzed for clinician.
Monitored in vitro device 102 is used to monitor whether implantable device tissue around occurs lesion and send prompting.
1 illustrate the structure of the lesion tissue monitoring system referring to the drawings.Implantable medical device is implanted into patient
In vivo, it include sensor 201, first processor module 202, charge coil, an at least main battery, an at least reserve battery,
Wake module 203 and first communication module 204.Wherein, sensor 201 is connected with first processor module 202, for that will gather
One or more physiological parameter be sent to first processor module 202, above-mentioned one or more physiological parameter can be can
The various parameters of patient body situation and/sign lesion tissue are characterized, such as body temperature, blood pressure, blood oxygen, germ etc. can sense
The sensor of these parameters includes body temperature trans, starch enzyme sensor, blood pressure sensor, antibody sensor, germ sensor
Patient oxter is can be located at Deng, body temperature trans, germ sensor can be located in the border circular areas that wound radius is 3-5cm.
Sensor 201 could be arranged to the one kind in the sensor, it is also possible to be set to by multiple sensor groups into sensor array
Row.First processor module 202 is connected with sensor 201, one or more for obtaining and locating the collection of reason sensor 201
Physiological signal, and treatment judgement is carried out, first processor module 202 is also connected with first communication module 204, wake module 203,
Operation for controlling above-mentioned two module.Wake module 203 is connected with first processor module 202 and sensor 201 respectively, uses
Waking up sensor in the control for receiving first processor module 202 carries out secondary detection.The treatment of first communication module 204 and first
Device module 202 is connected, for being communicated with second communication module 304, to realize implantable medical device 101 and monitored in vitro device
102 communication.The control charge coil of first processor module 202 charges to an at least main battery and an at least reserve battery；The
One processor module 202 also controls an at least reserve battery to be charged to an at least main battery.
Monitored in vitro device 102, is set in vitro, carries out data exchange to monitor patient's shape with implantable medical device 101
Condition, it includes that ultrasonic wave occurs module 301, ultrasonic wave receiver module 302, second processing device module 303, second communication module
304 and warning module 305.Wherein, ultrasonic wave transmitter module 301, ultrasonic wave receiver module 302 receive second processing device module
Order, periodically changed with detecting skin thickness near wound using ultrasonic wave.Above-mentioned ultrasonic wave occurs module 301 to be included surpassing
Sonic probe, the probe can be common shape, such as disc, and probe quantity can be one or more.Second processing device mould
There is module 301, ultrasonic wave receiver module 302, second communication module 304 and warning module 305 with ultrasonic wave respectively in block 303
It is connected, controls the operation of above-mentioned module, the first lesion threshold value for pre-setting and the while second processing device module 303 is stored with
Two lesion threshold values, for judging whether implantable medical device surrounding tissue occurs lesion.Second communication module 304 is used for and the
One communication module 204 communicates, to send possible Pathological Information.Warning module 305 is used to carry out early warning, early warning to possible lesion
The mode haptic signal such as the voice signal such as visual signal, buzzing and/or vibrations such as including LED.
The working method of the detailed description below implantable medical device lesion tissue monitoring system.System has is used for day
First working condition and the second working condition for determining lesion of often monitoring.Implantable medical device 101 is normally being used
During, system starts i.e. into the first working condition, and under the state, sensor 201 is configured in patient body and respectively gathers position
Put, collection patient items physiological parameter is simultaneously recorded to carry out monitor in real time, and ultrasonic wave transmitter module 301 is arranged in patient's wound
Mouthful nearby skin, receives the trigger signal of second processing device module 303, periodically to launching ultrasonic wave, ultrasonic wave arteries and veins in patient's body
It was punched through human body skin, fat and reached muscle, muscle reflection echo signal received the echo by ultrasonic wave receiver module 302, passed through
The pretreatment to signal is crossed, then sends result to second processing device module 303, calculating arrangement is carried out to data, to obtain skin
Skin thickness, and the skin thickness that obtains will be measured compared with the skin thickness of the last measurement of storage, when skin thickness change
Change during more than default first lesion threshold value, then implantable medical device surrounding tissue may occur lesion.Once judgement is possible to
Generation lesion, system is to start the second working condition.Now, second processing device module 303 i.e. start second communication module 304 with
First communication module 204 is communicated, and the control wake module 203 of first processor module 202 wakes up sensor 201 to be carried out targetedly
Secondary detection, body temperature is carried out according to the species that lesion may occur, germ, the detection of amylase or antibody will inspection after detection
Survey data to send again to second processing device module 303, and compared with default second lesion threshold value, if the secondary detection
Result reaches the second lesion threshold value, it is determined that implantable medical device tissue around occurs lesion, and warning module 305 is started immediately
Early warning is carried out, informs that patient and/or care provider have occurred and that lesion, it is necessary to treatment in time.
Further, the system also includes remote server 103 and doctor's main frame 104, and monitored in vitro device may also include the
Three communication modules 306, the third communication module 306 can be by being wirelessly or non-wirelessly connected to remote server 103.When it is determined that hair
After sick change, i.e., after system enters the second working condition, in addition to control warning module 305 carries out early warning, also by the third communication
Pathological Information is sent to remote server 103 by module 306, is available for doctor to be accessed in doctor's main frame, is easy to doctor to patient's
Quick disposal.
Further, for the patient of long periods of wear, the sensor 201 of implantable medical device 101 can also quilt
It is set to periodically be waken up the physiological parameter of detection implantable medical device tissue around and passes through first communication module 204 and the
Two communication modules 304 are sent to monitored in vitro device 102, and are uploaded to remote server 103 by third communication module 306, doctor
Life can check patient data by doctor's main frame 104.
Embodiment：The system also includes remote server 103 and doctor's main frame 104, and vitro detection device may also include the 3rd
Communication module, the third communication module of vitro detection device can be by being wirelessly or non-wirelessly connected to remote server, warning module
Pathological Information is also sent to by remote server by third communication module after early warning, is available for doctor to be accessed in doctor's main frame.
The sensor of implantable medical device can periodically be waken up the physiology ginseng of detection implantable medical device tissue around
Number is simultaneously sent to vitro detection device, and be uploaded to far by third communication module by first communication module and second communication module
Journey server, doctor can check patient data by doctor's main frame.
Claims (7)
1. the lesion tissue detecting system of a kind of charging, it is characterised in that：Including implantable medical device（101）And vitro detection
Device（102）；The implantable medical device（101）Implantation within a patient, including sensor assembly（201）, first processor mould
Block（202）, charge coil, at least a main battery, at least a reserve battery, wake module（203）And first communication module
（204）；The first processor module（202）The charge coil is controlled to an at least main battery and described at least standby
Charged with battery；The first processor module（202）An at least reserve battery described in control fills to an at least main battery
Electricity；The vitro detection device（102）, set in vitro, including there is module in ultrasonic wave（301）, ultrasonic wave receiver module
（302）, second processing device module（303）, warning module（305）, second communication module block（304）Carry out radio communication.
2. the lesion tissue detecting system for charging according to claim 1, it is characterised in that：The sensor assembly（201）
May include body temperature trans, germ sensor, starch enzyme sensor and antibody sensor.
3. the lesion tissue detecting system for charging according to claim 1, it is characterised in that：The vitro detection device（102）
The second processing device module（303）Periodically control the ultrasonic wave transmitter module（301）With the ultrasonic wave receiver module
（302）Skin thickness near detection wound, when skin thickness intensity of variation is more than the first lesion threshold value, then possibility is described can
Implantable medical device（101）There is lesion in surrounding tissue, by the second communication module（304）Set with the implantable medical
It is standby（101）The first communication module（204）Communication, sending may Pathological Information.
4. the lesion tissue detecting system for charging according to claim 1, it is characterised in that：The processor module controls institute
State wake module（203）Wake up the sensor assembly（201）Further detection, carries out body temperature, germ, amylase and antibody
Detection, the body temperature trans can be located at patient oxter, and the germ sensor can be located at the circle that wound radius is 3-5cm
In shape region, if testing result reaches the second lesion threshold value, it is determined that the possible implantable medical device（101）Tissue around
Lesion, by the first communication module（204）With the second communication module（304）Pathological Information is sent to described external
Detector（102）, the second processing device module（303）Control the warning module（305）Carry out early warning.
5. the lesion tissue detecting system for charging according to claim 1, it is characterised in that：The detecting system may also include far
Journey server（103）With doctor's main frame（104）, the vitro detection device（102）May also include third communication module（306）, institute
State vitro detection device（102）The third communication module（306）Can be by being wirelessly or non-wirelessly connected to the remote service
Device（103）, the warning module（305）Also by the third communication module after early warning（305）Pathological Information is sent to institute
State remote server（103）, doctor is available in doctor's main frame（104）Access.
6. the lesion tissue detecting system for charging according to claim 5, it is characterised in that：The sensor assembly（201）
The detection implantable medical device can be periodically waken up（101）The physiological parameter of tissue around simultaneously passes through the described first communication mould
Block（204）With the second communication module（304）It is sent to the vitro detection device（102）, and by the third communication mould
Block（306）It is uploaded to the remote server（103）, doctor can be by doctor's main frame（104）Check patient data.
7. the lesion tissue detecting system for charging according to claim 1, it is characterised in that：The main battery and described standby
Battery is Li-Ion rechargeable battery.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611268447.2A CN106667440B (en) | 2016-12-31 | 2016-12-31 | Charged tissue lesion detection system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611268447.2A CN106667440B (en) | 2016-12-31 | 2016-12-31 | Charged tissue lesion detection system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106667440A true CN106667440A (en) | 2017-05-17 |
| CN106667440B CN106667440B (en) | 2023-05-30 |
Family
ID=58850139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611268447.2A Active CN106667440B (en) | 2016-12-31 | 2016-12-31 | Charged tissue lesion detection system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106667440B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3813710A4 (en) * | 2018-06-26 | 2022-03-16 | Australian Institute of Robotic Orthopaedics Pty Ltd | Implant fit analysis |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000229078A (en) * | 1999-02-10 | 2000-08-22 | Japan Science & Technology Corp | Vascular lesion diagnositic system and diagnostic program memory storage medium |
| US20080262374A1 (en) * | 2007-04-19 | 2008-10-23 | Medtronic, Inc. | Event triggered infection monitoring |
| US20090024054A1 (en) * | 2007-07-20 | 2009-01-22 | Arnaud Lazarus | Implantable medical device |
| US20100305430A1 (en) * | 2007-09-26 | 2010-12-02 | Volker Troesken | Tissue marker |
| CN202957629U (en) * | 2012-11-16 | 2013-05-29 | 移康智能科技(上海)有限公司 | Double-battery powered electronic door viewer |
-
2016
- 2016-12-31 CN CN201611268447.2A patent/CN106667440B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000229078A (en) * | 1999-02-10 | 2000-08-22 | Japan Science & Technology Corp | Vascular lesion diagnositic system and diagnostic program memory storage medium |
| US20080262374A1 (en) * | 2007-04-19 | 2008-10-23 | Medtronic, Inc. | Event triggered infection monitoring |
| US20090024054A1 (en) * | 2007-07-20 | 2009-01-22 | Arnaud Lazarus | Implantable medical device |
| US20100305430A1 (en) * | 2007-09-26 | 2010-12-02 | Volker Troesken | Tissue marker |
| CN202957629U (en) * | 2012-11-16 | 2013-05-29 | 移康智能科技(上海)有限公司 | Double-battery powered electronic door viewer |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3813710A4 (en) * | 2018-06-26 | 2022-03-16 | Australian Institute of Robotic Orthopaedics Pty Ltd | Implant fit analysis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106667440B (en) | 2023-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2672888B1 (en) | Wireless, implantable electro-encephalography system | |
| EP1613396B1 (en) | Acoustic telemetry apparatus for intrabody communications | |
| AU2010302270B2 (en) | Continuous non-interfering health monitoring and alert system | |
| CN103458775A (en) | Device and method for detecting ophtalmic and/or brain diseases | |
| WO2007130177A1 (en) | Activity level feedback for managing obesity | |
| JP2012529308A (en) | Device for processing and transmitting measurement signals for monitoring and / or controlling medical implants, diagnostic devices or biological techniques | |
| US9968789B2 (en) | Temporary external pacemaker and monitor | |
| WO2022018529A1 (en) | Diagnosis or treatment via vestibular and cochlear measures | |
| US11375905B2 (en) | Performing one or more pulse transit time measurements based on an electrogram signal and a photoplethysmography signal | |
| US20220061743A1 (en) | Detection of seizure and stroke | |
| CN106730342B (en) | Implanted sacral nerve stimulator with electrode displacement prompt function | |
| US20150273215A1 (en) | Systems and methods for assessment of pain and other parameters during trial neurostimulation | |
| CN106667440A (en) | Chargeable system for detecting pathological change of tissue | |
| CN106621045A (en) | Tissue leison detection system subject to charging control | |
| CN106510768A (en) | Tissue pathological change detection system with temperature control and charging functions | |
| CN106667437A (en) | System for predicting postoperative complication of implantable medical device | |
| US20220132941A1 (en) | Article of clothing and method for controlling cells using such an article of clothing | |
| WO2022018531A1 (en) | Vestibular clinical support system functionality | |
| CN112492873A (en) | Implantable devices and methods of use thereof | |
| US11464985B2 (en) | Implantable medical device using internal sensors to determine when to switch operational modes | |
| US20230364435A1 (en) | Implantable medical device using internal sensors to determine when to switch operational modes | |
| CN114340492A (en) | Wearable device for monitoring physiological changes and method of use thereof | |
| EP4059425A1 (en) | Detection and/or prediction of a medical condition using atrial fibrillation and glucose measurements | |
| US20220409907A1 (en) | Hibernation of electronics in an implantable stimulator | |
| WO2017041138A1 (en) | Systems and methods of neuromodulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |